| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Institute of Child Health |
| Information provided by: | Institute of Child Health |
| ClinicalTrials.gov Identifier: | NCT00452829 |
Purpose
The aim of the study is to develop a randomised, double blind clinical trial to compare (i) folic acid plus inositol, with (ii) folic acid plus placebo, for prevention of recurrent neural tube defects.
| Condition | Intervention | Phase |
|
Recurrent Neural Tube Defects |
Drug: Folic Acid and inositol Drug: Folic acid and placebo |
Phase I |
| MedlinePlus related topics: | Neural Tube Defects |
| ChemIDplus related topics: | Folic acid Inositol |
| Study Type: | Interventional |
| Study Design: | Randomized, Double-Blind, Placebo Control, Parallel Assignment |
| Official Title: | Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study) |
Eligibility
| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Contacts and Locations| Contact: Mrs K Burren | 0207 905 2326 | ponti@ich.ucl.ac.uk |
| United Kingdom | |||||
| Neural Development Unit, Institute of Child Health | Recruiting | ||||
| London, United Kingdom, WC1N 1EH | |||||
| Contact: Katie Burren 0207 905 2326 | |||||
| Principal Investigator: Andrew Copp, Prof | |||||
| Institute of Child Health |
| Principal Investigator: | Andrew Copp, Prof | Institute Of Child Health and Great Ormond Street Hospital |
More Information
| Study ID Numbers: | 05ND07 |
| First Received: | March 27, 2007 |
| Last Updated: | March 27, 2007 |
| ClinicalTrials.gov Identifier: | NCT00452829 |
| Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
|
|
|
|
|
